1. Home
  2. ASRT vs MCHX Comparison

ASRT vs MCHX Comparison

Compare ASRT & MCHX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ASRT
  • MCHX
  • Stock Information
  • Founded
  • ASRT 1995
  • MCHX 2003
  • Country
  • ASRT United States
  • MCHX United States
  • Employees
  • ASRT N/A
  • MCHX N/A
  • Industry
  • ASRT Biotechnology: Pharmaceutical Preparations
  • MCHX Business Services
  • Sector
  • ASRT Health Care
  • MCHX Consumer Discretionary
  • Exchange
  • ASRT Nasdaq
  • MCHX Nasdaq
  • Market Cap
  • ASRT 79.1M
  • MCHX 84.3M
  • IPO Year
  • ASRT 1997
  • MCHX 2004
  • Fundamental
  • Price
  • ASRT $0.81
  • MCHX $1.94
  • Analyst Decision
  • ASRT Strong Buy
  • MCHX
  • Analyst Count
  • ASRT 1
  • MCHX 0
  • Target Price
  • ASRT $3.00
  • MCHX N/A
  • AVG Volume (30 Days)
  • ASRT 289.6K
  • MCHX 55.7K
  • Earning Date
  • ASRT 08-11-2025
  • MCHX 08-12-2025
  • Dividend Yield
  • ASRT N/A
  • MCHX N/A
  • EPS Growth
  • ASRT N/A
  • MCHX N/A
  • EPS
  • ASRT N/A
  • MCHX N/A
  • Revenue
  • ASRT $117,099,000.00
  • MCHX $47,534,000.00
  • Revenue This Year
  • ASRT N/A
  • MCHX $5.77
  • Revenue Next Year
  • ASRT $11.91
  • MCHX N/A
  • P/E Ratio
  • ASRT N/A
  • MCHX N/A
  • Revenue Growth
  • ASRT N/A
  • MCHX N/A
  • 52 Week Low
  • ASRT $0.51
  • MCHX $1.26
  • 52 Week High
  • ASRT $1.38
  • MCHX $2.40
  • Technical
  • Relative Strength Index (RSI)
  • ASRT 66.13
  • MCHX 46.87
  • Support Level
  • ASRT $0.71
  • MCHX $1.37
  • Resistance Level
  • ASRT $0.86
  • MCHX $2.14
  • Average True Range (ATR)
  • ASRT 0.03
  • MCHX 0.16
  • MACD
  • ASRT 0.01
  • MCHX -0.02
  • Stochastic Oscillator
  • ASRT 70.69
  • MCHX 74.03

About ASRT Assertio Holdings Inc.

Assertio Holdings Inc is a pharmaceutical company. It is engaged in providing solutions to advance patient care in the areas of neurology, orphan and specialty medicines. The company markets three FDA-approved products for various neurological conditions including Gralise, tablets for the management of postherpetic neuralgia; CAMBIA, for acute treatment of migraine attacks with or without aura in adults of age or older and Zipsor, liquid-filled capsules for relief of mild to moderate pain.

About MCHX Marchex Inc. Class B

Marchex Inc is a conversational analytics and solutions company that helps businesses connect, drive, measure, convert callers into customers, and connect the voice of the customer to their business. It delivers data insights and incorporates artificial intelligence (AI)-powered functionality that drives insights and solutions to help companies find, engage, and support their customers across voice and text-based communication channels. The group enables sales and marketing teams to deliver the buying experiences that today's customers expect. The company generates the majority of its revenues from core analytics and solutions services. The company operates in the United States, Canada, and other countries.

Share on Social Networks: